3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Dermatologic
1
Conditions
Multiple Myeloma
14
Leukemia, Myeloid, Acute
13
Lymphoma
12
Neoplasm Metastasis
11
Pancreatic Neoplasms
9
Prostatic Neoplasms
8
Myelodysplastic Syndromes
8
Burkitt Lymphoma
8
Breast Neoplasms
8
Glioma
7
Colorectal Neoplasms
7
Sarcoma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Triple Negative Breast Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neuroblastoma
5
Lymphoma, T-Cell
5
Lymphoma, Non-Hodgkin
5
Central Nervous System Neoplasms
5
Carcinoma, Renal Cell
5
Wilms Tumor
4
Squamous Cell Carcinoma of Head and Neck
4
Rhabdoid Tumor
4
Ovarian Neoplasms
4
Oropharyngeal Neoplasms
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Lung Neoplasms
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Interventions
temsirolimus
1
Valproic Acid
1
Specimen Handling
1
Sirolimus
1
Immunoglobulin G
1
Disulfides
1
Cetuximab
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Soft Tissue Neoplasms
×
Biopsy
×
30 days
×
Clear all
NCT07062003
2026-06-04
MBRT1
Mayo Clinic
Phase NA
Recruiting
60 enrolled